Post-effective amendment to a registration statement that is not immediately effective upon filing

INCOME TAXES (Tables)

v3.22.1
INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2021
Income Tax Disclosure [Abstract]  
Schedule of provision for income taxes
               
   

Year Ended

December 31,

 
    2021     2020  
Current tax provision:                
Federal   $

    $ (28
State     1        
Foreign     (691     (754
Total current     (690     (782
                 
Deferred tax provision:                
Federal            
State            
Total deferred            
Total income tax benefit   $ (690   $ (782
Schedule of income tax benefit
             
Country     NOL Carryforwards     Expiry Terms
U.K.     $ 262,434     Does not expire
U.S.       207,015     Expires in up to 16 years
U.S.       24,632     Does not expire
Australia       5,220     Does not expire
Israel       281,173     Does not expire
Finland       338     Expires in up to 7 years
Other       1,991     Expires in up to 5 years
Schedule of deferred tax assets
               
    As of
December 31,
 
    2021     2020  
Net operating loss carryforwards   $ 154,210     $ 145,355  
Fixed assets     2,037       2,539  
R&D amortization     6,613       6,393  
Accruals and reserves     10,813       8,238  
R&D and other credits     4,267       4,191  
Share-based compensation     2,645       2,306  
Total deferred tax assets     180,585       169,022  
Intangible assets     (1,145 )     (1,395 )
Total deferred tax liabilities     (1,145 )     (1,395 )
Valuation allowance     (179,440 )     (167,627 )
Total deferred tax assets, net   $     $  
Schedule of reconciliation of income taxes
               
    Years Ended
December 31,
 
    2021     2020  
Expected income tax benefit at U.S. rates   $ 14,713     $ 5,549  
Difference between U.S. rate and rates applicable to subsidiaries in other jurisdictions     238       (301 )
Expenditures not deductible for tax purposes     (198 )     (43 )
Non-deductible officer compensation     (1,656 )      
Fair market value changes     1,590        
Expiry of foreign taxable losses     (4,493 )     6,218  
Other     599       502  
Valuation allowance on tax benefits     (11,817 )     (13,385 )
UK R&D tax credits     1,714       2,242  
Income tax benefit   $ 690     $ 782